ID
32630
Descrizione
Study ID: 102248 Clinical Study ID: 102248 Study Title: Multi-Center Study to Assess the Efficacy, Safety and Immunogenicity of 2 or 3 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine Given Concomitantly With Routine EPI Vaccinations in Healthy Infants Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00241644 Study Link: https://clinicaltrials.gov/ct2/show/NCT00241644 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 3 Study Recruitment Status: Completed Generic Name: Rotavirus Vaccine Trade Name: Rotarix Study Indication: Infections, Rotavirus The visits are defined as follows: Visit 1: (Study/Participation) Day 0, Age: 5-10 weeks, Dose 1 Visit 2: (Study/Participation) Month 1, 30-48 days after Visit 1, Dose 2 Visit 3: (Study/Participation) Month 2, 30-48 days after Visit 2, Dose 3 Visit 4: (Study/Participation) Month 3, 30-48 days after Visit 3, Visit 5: (Study/Participation) 1 year of age, 343-391 days of age For amendment 5: Visit 5: (Study/Participation) 21-48 days after Visit 4 Visit 6: (Study/Participation) 1 year of age, 343-391 days of age This form asks, if and when routine vaccine administrations have taken place and should be checked at visits 1-3.
collegamento
https://clinicaltrials.gov/ct2/show/NCT00241644
Keywords
versioni (2)
- 01/11/18 01/11/18 -
- 09/11/18 09/11/18 - Sarah Riepenhausen
Titolare del copyright
GlaxoSmithKline
Caricato su
9 novembre 2018
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY-NC 3.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
Efficacy, Safety and Immunogenicity of Oral HRV Vaccine NCT00241644
Routine Vaccine Administration
- StudyEvent: ODM
Descrizione
Routine Vaccine Administrations
Alias
- UMLS CUI-1
- C2368628
- UMLS CUI-2
- C0205547
Descrizione
If Yes is ticked, the above vaccines are not to be reported again in the Concomitant Vaccination section at the end of the CRF. Any other vaccines administered during the study period are to be recorded in the Concomitant Vaccination section at the end of the CRF.
Tipo di dati
boolean
Alias
- UMLS CUI [1]
- C0032375
Descrizione
OPV Vaccination Date
Tipo di dati
date
Alias
- UMLS CUI [1,1]
- C0032375
- UMLS CUI [1,2]
- C0011008
Descrizione
If Yes is ticked, the above vaccines are not to be reported again in the Concomitant Vaccination section at the end of the CRF. Any other vaccines administered during the study period are to be recorded in the Concomitant Vaccination section at the end of the CRF.
Tipo di dati
boolean
Alias
- UMLS CUI [1,1]
- C2240392
- UMLS CUI [1,2]
- C3653328
- UMLS CUI [1,3]
- C0012559
Descrizione
DTPw-HB/Hib vaccination Date
Tipo di dati
text
Alias
- UMLS CUI [1,1]
- C2240392
- UMLS CUI [1,2]
- C3653328
- UMLS CUI [1,3]
- C0012559
- UMLS CUI [1,4]
- C1115436
Similar models
Routine Vaccine Administration
- StudyEvent: ODM
C0205547 (UMLS CUI-2)
C0011008 (UMLS CUI [1,2])
C3653328 (UMLS CUI [1,2])
C0012559 (UMLS CUI [1,3])
C3653328 (UMLS CUI [1,2])
C0012559 (UMLS CUI [1,3])
C1115436 (UMLS CUI [1,4])